Medpace
MEDP
319 hedge funds and large institutions have $4.59B invested in Medpace in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 100 increasing their positions, 134 reducing their positions, and 37 closing their positions.
467% more call options, than puts
Call options by funds: $9.66M | Put options by funds: $1.71M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
19% more capital invested
Capital invested by funds: $3.84B → $4.59B (+$746M)
19% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 37
1.15% more ownership
Funds ownership: 77.37% → 78.53% (+1.2%)
1% more funds holding
Funds holding: 316 → 319 (+3)
25% less repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 134
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$43.2M |
| 2 |
ESCM
Echo Street Capital Management
New York
|
+$32.3M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$31.6M |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$30.9M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$28.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PG
Pendal Group
Sydney,
Australia
|
-$29.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$28.6M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$24.5M |
| 4 |
Renaissance Technologies
New York
|
-$21.3M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$15.8M |
MEDP Hedge Fund Activity: Q1 2021 in Review
319 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2021, worth a combined $4.59B — up 19% from $3.84B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new MEDP positions and 37 closed out — a net gain of 7 holders — while 100 added to existing stakes and 134 trimmed.
The largest buyer was Riverbridge Partners, opening a new position worth an estimated $43.2M. The largest seller was Pendal Group, cutting an estimated $29.8M.
- 319 institutional investors held Medpace (MEDP) as of Q1 2021, up from 316 in Q4 2020.
- Funds reported $4.59B of Medpace stock for Q1 2021, up 19% quarter-over-quarter.
- 44 funds opened new Medpace positions in Q1 2021 and 37 closed out, a net change of +7 holders.
- The largest Medpace buyer in Q1 2021 was Riverbridge Partners, an estimated $43.2M added.
- The largest Medpace seller in Q1 2021 was Pendal Group, an estimated $29.8M sold.
Based on aggregated 13F filings for Q1 2021.